A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses.
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses.
复制标题
DOI:
10.1038/s41467-021-25729-7
复制
发表时间:
2021-09-17
影响因子:
16.6
通讯作者:
Clevers H
中科院分区:
文献类型:
--
作者:
Beumer J;Geurts MH;Lamers MM;Puschhof J;Zhang J;van der Vaart J;Mykytyn AZ;Breugem TI;Riesebosch S;Schipper D;van den Doel PB;de Lau W;Pleguezuelos-Manzano C;Busslinger G;Haagmans BL;Clevers H
Rapid identification of host genes essential for virus replication may expedite the generation of therapeutic interventions. Genetic screens are often performed in transformed cell lines that poorly represent viral target cells in vivo, leading to discoveries that may not be translated to the clinic. Intestinal organoids are increasingly used to model human disease and are amenable to genetic engineering. To discern which host factors are reliable anti-coronavirus therapeutic targets, we generate mutant clonal IOs for 19 host genes previously implicated in coronavirus biology. We verify ACE2 and DPP4 as entry receptors for SARS-CoV/SARS-CoV-2 and MERS-CoV respectively. SARS-CoV-2 replication in IOs does not require the endosomal Cathepsin B/L proteases, but specifically depends on the cell surface protease TMPRSS2. Other TMPRSS family members were not essential. The newly emerging coronavirus variant B.1.1.7, as well as SARS-CoV and MERS-CoV similarly depended on TMPRSS2. These findings underscore the relevance of non-transformed human models for coronavirus research, identify TMPRSS2 as an attractive pan-coronavirus therapeutic target, and demonstrate that an organoid knockout biobank is a valuable tool to investigate the biology of current and future emerging coronaviruses. Rapid identification of host genes essential for virus replication may expedite the generation of therapeutic interventions. Here the authors generate mutant clonal intestinal organoids for 19 host genes previously implicated in coronavirus biology and identify the cell surface protease TMPRSS2 as a potential therapeutic target.
登录
查看更多内容
DOI:
10.1126/science.abd3072
发表时间:
2020-11-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Daly JL;Simonetti B;Klein K;Chen KE;Williamson MK;Antón-Plágaro C;Shoemark DK;Simón-Gracia L;Bauer M;Hollandi R;Greber UF;Horvath P;Sessions RB;Helenius A;Hiscox JA;Teesalu T;Matthews DA;Davidson AD;Collins BM;Cullen PJ;Yamauchi Y
通讯作者:
Yamauchi Y
影响因子:
64.5
作者:
Daniloski Z;Jordan TX;Wessels HH;Hoagland DA;Kasela S;Legut M;Maniatis S;Mimitou EP;Lu L;Geller E;Danziger O;Rosenberg BR;Phatnani H;Smibert P;Lappalainen T;tenOever BR;Sanjana NE
通讯作者:
Sanjana NE
影响因子:
--
作者:
Hulswit RJ;de Haan CA;Bosch BJ
通讯作者:
Bosch BJ
DOI:
10.1016/s0140-6736(03)13967-0
发表时间:
2003-07-26
期刊:
Lancet (London, England)
影响因子:
--
作者:
Kuiken T;Fouchier RA;Schutten M;Rimmelzwaan GF;van Amerongen G;van Riel D;Laman JD;de Jong T;van Doornum G;Lim W;Ling AE;Chan PK;Tam JS;Zambon MC;Gopal R;Drosten C;van der Werf S;Escriou N;Manuguerra JC;Stöhr K;Peiris JS;Osterhaus AD
通讯作者:
Osterhaus AD
影响因子:
11.8
作者:
Kaye M
通讯作者:
Kaye M